10x Genomics Stock Slides Amid German Patent Court Ruling
Bruker's NanoString Secures Patent Case Win in Germany
Bruker (BRKR) said Tuesday that the German Federal Patent Court has ruled in favor of its unit, NanoString Technologies Germany, by invalidating 10x Genomics' (TXG) European patent No. 2794928B1 in Ge
NanoString Technologies' Strategic Asset Sale and Bankruptcy Outcome
Press Release: Bruker Completes Asset Acquisition of NanoString Business
Bruker Completes Asset Acquisition of NanoString Business Adds Highly Complementary Business in Gene Expression Profiling and Spatial Transcriptomics for Discovery and Translational Research BILLERI
NanoString Technologies Announces Chapter 11 Bankruptcy
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies
Bruker (BRKR) said Monday that it has signed an asset purchase agreement with NanoString Technologies, a provider of solutions for spatial transcriptomics and gene expression analysis, for approximate
Bruker Expects to Fund Acquisition With Cash on Hand and Established Debt Instruments >BRKR
Bruker Expects to Fund Acquisition With Cash on Hand and Established Debt Instruments >BRKR
Bruker Will Acquire NanoString Business for About $392.6M in Cash and Assumption of Certain Liabilities >BRKR
Bruker Will Acquire NanoString Business for About $392.6M in Cash and Assumption of Certain Liabilities >BRKR
Bruker Enters Definitive Acquisition Agreement With NanoString Technologies >BRKR NSTGQ
Bruker Enters Definitive Acquisition Agreement With NanoString Technologies >BRKR NSTGQ
Press Release: Bruker to Acquire the NanoString Business in an Asset Deal
Bruker to Acquire the NanoString Business in an Asset Deal NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clini
Bruker to Acquire NanoString Technologies
Bruker has agreed to acquire NanoString Technologies for about $392.6 million in cash.
NanoString: Bruker to Buy Substantially All Assets for About $392.6M Cash Consideration
NanoString: Bruker to Buy Substantially All Assets for About $392.6M Cash Consideration
NanoString: Bruker Submitted a Qualifying Bid on April 12; Revised Offer Was Selected After April 16 Auction
NanoString: Bruker Submitted a Qualifying Bid on April 12; Revised Offer Was Selected After April 16 Auction
NanoString Technologies to Be Acquired by Bruker Corporation
Bruker Wins Competitive Auction Acquisition Ensures Continued Customer Access to NanoString's Products Transaction Expected to Close in early-May 2024 NanoString Technologies, Inc. ("NanoString" or "the Company"),
NanoString Technologies Issues Chapter 11 Caution to Investors
Patient Square Capital to Acquire NanoString Technologies for $220M
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
Binding Agreement to Acquire Substantially All NanoString Assets for $220 Million Pending Bankruptcy Court ApprovalAgreement Represents Major Step in Financial Restructuring and Provides Continuity fo
12 Health Care Stocks Moving In Monday's Intraday Session
GainersRenalytix (NASDAQ:RNLX) stock rose 490.4% to $2.25 during Monday's regular session. The market value of their outstanding shares is at $112.4 million. Regencell Bioscience (NASDAQ:RGC) stock ro
Canaccord Genuity Downgrades NanoString Technologies to Hold From Buy, Adjusts Price Target to $0.25 From $1.50
NanoString Technologies (NSTG) has an average rating of hold and price targets ranging from $0.25 to $15, according to analysts polled by Capital IQ.
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSingular Genomics Sys (NASDAQ:OMIC) shares moved upwards by 17.9% to $0.66 during Friday's after-market session. The market value of their outstanding shares is at $48.4 million. Vaccinex (NASD
No Data